Announcements Trials
Browse Landscape

Phase

Phase 1/2 5Phase NA 3Phase EARLY_PHASE1 3Phase 2 2Phase 1 2

Status

Recruiting 27Unknown 15Terminated 8Completed 8Not yet recruiting 5Active not recruiting 4Withdrawn 2

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Breast Neoplasms 24Carcinoma, Non-Small-Cell Lung 20Neoplasms 19Colorectal Neoplasms 19Recurrence 17Pancreatic Neoplasms 17Multiple Myeloma 15Advanced Solid Tumors 13Prostatic Neoplasms 12Advanced Solid Tumor 12Stomach Neoplasms 10Ovarian Neoplasms 10Leukemia, Myeloid, Acute 10Carcinoma, Hepatocellular 10Triple Negative Breast Neoplasms 8Neoplasm Metastasis 7Melanoma 7Squamous Cell Carcinoma of Head and Neck 6Small Cell Lung Carcinoma 6Lymphoma, Large B-Cell, Diffuse 6Head and Neck Neoplasms 6Glioblastoma 6Urinary Bladder Neoplasms 5Solid Tumors 5Solid Tumor 5Lymphoma, B-Cell 5Lung Neoplasms 5Liver Neoplasms 5Glioma 5Endometrial Neoplasms 5

Interventions

toripalimab 1spartalizumab 1sintilimab 1osimertinib 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1/2 × Not yet recruiting × Solid Tumor × Clear all
NCT07623707 2026-06-03

A Study of FG-B901 Monotherapy or Combination With Chemotherapy in Advanced or Metastatic Solid Tumors

FutureGen Biopharmaceutical (Beijing) Co., Ltd

Phase 1/2 Not yet recruiting
264 enrolled
Other solid neoplasm

Solid Tumor

NCT07612137 2026-05-28

Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1/2 Not yet recruiting
282 enrolled
Other solid neoplasm

Solid Tumor

NCT07245901 2025-11-24

Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 1/2 Not yet recruiting
60 enrolled
Other solid neoplasm

Solid Tumor

NCT07140393 2025-08-24

A Study of HRS-4508 in Combination With Other Anti-tumor Therapy for Solid Tumor

Jiangsu HengRui Medicine Co., Ltd.

Phase 1/2 Not yet recruiting
120 enrolled
Other solid neoplasm

Solid Tumor

NCT06949761 2025-04-29

A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of QLC1101 in Combination With Other Therapies in the Treatment of Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation

Qilu Pharmaceutical Co., Ltd.

Phase 1/2 Not yet recruiting
240 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡